Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-10

  Einefors, Rickard ^a   Kogler, Ulrika ^a   Ellberg, Carolina ^a   Olsson, Håkan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmune diseases; Breast cancer; ER negative; Hypersensitivities; Immunostimulatory therapy; Premenopausal

Indexed keywords

EID: 84887292491     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-357     Document Type: Article

References (27)

1. Ahmad Al Obaidi AH, Mohamed Al Samarai AG, Yahya Al Samarai AK, Al Janabi JM (2008) The predictive value of IgE as biomarker in asthma. J Asthma 45(8):654-663. doi:10.1080/02770900802126958.
2. Atassi MZ, Casali P (2008) Molecular mechanisms of autoimmunity. Autoimmunity 41(2):123-132. doi:10.1080/08916930801929021.
3. Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA (2005) Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol 23(25):6043-6053. doi:10.1200/JCO.2005.06.205.
4. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM (2012) Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer. N Engl J Med. doi:10.1056/NEJMoa1200694.
5. Calabro A, Beissbarth T, Kuner R, Stojanov M, Benner A, Asslaber M, Ploner F, Zatloukal K, Samonigg H, Poustka A, Sultmann H (2009) Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res Treat 116(1):69-77. doi:10.1007/s10549-008-0105-3.
6. Cookson W (2004) The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 4(12):978-988. doi:10.1038/nri1500.
7. Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007) Epidemiology of autoimmune diseases in Denmark. J Autoimmun 29(1):1-9. doi:10.1016/j.jaut.2007.05.002.
8. Ellberg C, Olsson H (2011) Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer. BMC Cancer 11:497. doi:10.1186/1471-2407-11-497.
9. Ellberg C, Jonsson G, Olsson H (2010) Can a phenotype for recessive inheritance in breast cancer be defined? Fam Cancer 9(4):525-530. doi:10.1007/s10689-010-9355-4.
10. Ellberg C, Jernstrom H, Olsson H (2012) Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study. Breast Cancer Res Treat 131 (1):177-186. doi:10.1007/s10549-011-1707-8.
11. Hemminki K, Liu X, Ji J, Forsti A, Sundquist J, Sundquist K (2012) Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol. doi:10.1016/j.ygyno.2012.07.100.
12. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbe C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8):711-723. doi:10.1056/NEJMoa1003466.
13. Hwang CY, Chen YJ, Lin MW, Chen TJ, Chu SY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN (2012) Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer 130(5):1160-1167. doi:10.1002/ijc.26105.
14. Jernstrom H, Frenander J, Ferno M, Olsson H (1999) Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients. Br J Cancer 80(9):1453-1458. doi:10.1038/sj.bjc.6690543.
15. Ji J, Liu X, Sundquist K, Sundquist J (2011) Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology 50(8):1513-1518. doi:10.1093/rheumatology/ker143.
16. Kumar V, Abbas A (ed) (2007) Robbins Basic Pathology, 8th edition. Saunders/Elsevier, Philadelphia, PA.
17. Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM (2011) Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 117(6):1163-1171. doi:10.1002/cncr.25524.
18. Marrack P, Kappler J, Kotzin BL (2001) Autoimmune disease: why and where it occurs. Nat Med 7(8):899-905. doi:10.1038/90935.
19. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359(9310):909-919. doi:10.1016/S0140-6736(02)08020-0.
20. Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO (2005) Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol 18(1):26-35. doi:10.1038/modpathol.3800255.
21. Sanderson K, Scotland R, Lee P, Liu D, Groshen S, Snively J, Sian S, Nichol G, Davis T, Keler T, Yellin M, Weber J (2005) Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. J Clin Oncol 23(4):741-750. doi:10.1200/JCO.2005.01.128.
22. Simeone E, Ascierto PA (2012) Immunomodulating antibodies in the treatment of metastatic melanoma: The experience with anti-CTLA-4, anti-CD137, and anti-PD1. J Immunotoxicol. doi:10.3109/1547691X.2012.678021.
23. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M (2012) Safety, activity, and immune correlates of Anti-PD-1 antibody in cancer. N Engl J Med. doi:10.1056/NEJMoa1200690.
24. Turesson C, Matteson EL (2012) Malignancy as a comorbidity in rheumatic diseases. Rheumatology. doi:10.1093/rheumatology/kes189.
25. Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N, Walldius G, Lambe M, Jungner I, Holmberg L (2010) Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer causes & control: CCC 21(10):1657-1667. doi:10.1007/s10552-010-9594-6.
26. Vojtechova P, Martin RM (2009) The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis. Cancer causes & control: CCC 20(7):1091-1105. doi:10.1007/s10552-009-9334-y.
27. Weinberg RA (ed) (2007) The biology of cancer. Garland Scienc, Taylor and Francis Group, LLC.